US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CAR-T Concept

1,565.03

+29.621.93%

Number of Gainers:2

Number of Losers:- -

Number of Flat:- -

PE:- -

High:1,576.53

Open:1,538.50

Low:1,538.50

Close:1,535.40

Volume:17.17M

Turnover:2.11B

Market Cap:406.81B

Float Cap:394.40B

Loading ...

Gilead - for Q3, Co Currently Expects $170.4 Mln in Acquired Ipr&D Expenses

THOMSON REUTERS

Gilead: for Q3, Co Sees Acquired Ipr&D Expenses to Represent Charge of About $0.11 to Both Gaap and Non-Gaap EPS

THOMSON REUTERS

Bernstein Remains a Buy on Gilead Sciences (GILD)

Gilead Sciences (GILD) Gets a Buy from TD Cowen

Gilead Reaches Settlement To Block Biktarvy Generics Until 2036

Benzinga_recent_news

BUZZ-Gilead up after settling patent litigations with some generic drugmakers

BRIEF-Gilead Sciences Inc Announces Settlement Agreements With Lupin, Cipla And Laurus Labs - SEC Filing

Gilead Sciences Inc - Announces Settlement Agreements With Lupin, Cipla and Laurus Labs to Resolve Patent Litigations - SEC Filing

THOMSON REUTERS

Gilead Sciences Inc - No Generic Entry for Biktarvy Expected Before April 1, 2036 - SEC Filing

THOMSON REUTERS

Gilead Sciences Reaches Settlement to Delay U.S. Generic Versions of Biktarvy Until 2036

Gilead's Lost Decade Is Over. Time To Buy In. -- Barron's

Gilead Sciences Inc. Reports Acquisition of Common Shares of Assembly Biosciences Inc

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2025-10-03

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4578/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4578","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","market":"US","secType":"PLATE","nameCN":"CAR-T Concept","latestPrice":1565.0261,"timestamp":1760731199999,"preClose":1535.4019,"halted":0,"volume":17171615,"delay":0,"changeRate":0.019294,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":29.624268,"latestTime":"10-17 16:00:00 EDT","open":1538.4999,"high":1576.5337,"low":1538.4999,"amount":2114065436.749296,"amplitude":0.024771,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1760947200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":6.485206,"peRate":20.028615,"turnoverRate":0.005571,"increases":2,"decrements":0,"flats":0,"marketCap":406812655616,"floatMarketCap":394400251904},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","high":1576.5337,"amplitude":0.024771,"preClose":1535.4019,"low":1538.4999,"pbRate":"6.485206","latestPrice":1565.0261,"volume":17171615,"delay":0,"open":1538.4999,"prevYearClose":1164.883,"prevWeekClose":1527.2168,"prevMonthClose":1484.4005,"prevQuarterClose":1484.4005,"fiveDayClose":1527.2168,"twentyDayClose":1459.6134,"sixtyDayClose":1414.3706,"secType":"PLATE","market":"US","turnoverRate":0.005571,"peRate":20.028615,"marketCap":406812655616,"floatMarketCap":394400251904,"timestamp":1760731199999,"nameCN":"CAR-T Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4578\",,,,undefined,":{"bkCode":"BK4578","up":2,"down":0,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4578\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2573995859","title":"Gilead - for Q3, Co Currently Expects $170.4 Mln in Acquired Ipr&D Expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2573995859","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573995859?lang=en_us&edition=fundamental","pubTime":"2025-10-08 04:25","pubTimestamp":1759868714,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nFWN3VN2UO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1674673691.USD","LU0114720955.EUR","BK4578","LU1839511570.USD","IE00B3T34201.USD","LU1778281490.HKD","LU1571399168.USD","LU1066051498.USD","BK4588","LU2089984988.USD","LU2087621335.USD","IE00BZ1G4Q59.USD","IE00BSNM7G36.USD","LU0320765992.SGD","IE0002270589.USD","BK4583","IE00B7SZLL34.SGD","SG9999015978.USD","LU1066053197.SGD","LU2468319806.SGD","LU2324357040.USD","BK4566","IE00BKVL7J92.USD","BK4139","LU0289739699.SGD","LU1585245621.USD","IE00B19Z3B42.SGD","SG9999015952.SGD","LU0823416689.USD","BK4550","LU0882574055.USD","LU0889565916.HKD","LU1430594728.SGD","LU0109394709.USD","LU0058720904.USD","SG9999015986.USD","LU1674673428.USD","SG9999015945.SGD","BK4568","LU0234570918.USD","GILD","BK4532","IE00B19Z3581.USD","BK4585"],"gpt_icon":0},{"id":"2573995856","title":"Gilead: for Q3, Co Sees Acquired Ipr&D Expenses to Represent Charge of About $0.11 to Both Gaap and Non-Gaap EPS","url":"https://stock-news.laohu8.com/highlight/detail?id=2573995856","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573995856?lang=en_us&edition=fundamental","pubTime":"2025-10-08 04:25","pubTimestamp":1759868714,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nFWN3VN2UO:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1778281490.HKD","IE00B3T34201.USD","IE00BZ1G4Q59.USD","SG9999015945.SGD","LU0109394709.USD","IE00BKVL7J92.USD","LU0058720904.USD","BK4588","IE0002270589.USD","BK4139","LU1585245621.USD","LU1571399168.USD","SG9999015986.USD","LU0234570918.USD","IE00B19Z3B42.SGD","LU1674673691.USD","LU1430594728.SGD","LU2324357040.USD","GILD","BK4532","LU2087621335.USD","BK4585","LU1839511570.USD","LU0114720955.EUR","BK4578","LU1066051498.USD","BK4550","BK4568","IE00BSNM7G36.USD","LU2089984988.USD","IE00B19Z3581.USD","SG9999015952.SGD","LU2468319806.SGD","LU0823416689.USD","LU0320765992.SGD","BK4566","IE00B7SZLL34.SGD","LU0289739699.SGD","LU1066053197.SGD","BK4583","LU0882574055.USD","SG9999015978.USD","LU0889565916.HKD","LU1674673428.USD"],"gpt_icon":0},{"id":"2573596934","title":"Bernstein Remains a Buy on Gilead Sciences (GILD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2573596934","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573596934?lang=en_us&edition=fundamental","pubTime":"2025-10-07 23:15","pubTimestamp":1759850127,"startTime":"0","endTime":"0","summary":"In a report released today, Courtney Breen from Bernstein reiterated a Buy rating on Gilead Sciences, with a price target of $135.00. The company’s...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bernstein-remains-a-buy-on-gilead-sciences-gild-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bernstein-remains-a-buy-on-gilead-sciences-gild-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999015952.SGD","IE00B19Z3B42.SGD","LU1674673691.USD","BK4550","BK4139","LU1585245621.USD","IE00BZ1G4Q59.USD","LU1066051498.USD","BK4588","IE00BKVL7J92.USD","LU0320765992.SGD","GILD","LU2089984988.USD","SG9999015978.USD","LU0109394709.USD","LU0234570918.USD","BK4583","SG9999015986.USD","IE0002270589.USD","IE00BSNM7G36.USD","BK4566","IE00B19Z3581.USD","BK4532","LU0114720955.EUR","BK4568","LU2087621335.USD","BK4585","LU0058720904.USD","LU1066053197.SGD","IE00B7SZLL34.SGD","LU2324357040.USD","LU0889565916.HKD","LU1778281490.HKD","LU0289739699.SGD","LU1430594728.SGD","BK4578","LU0823416689.USD","LU1839511570.USD","LU0882574055.USD","SG9999015945.SGD","LU1571399168.USD","IE00B3T34201.USD","LU1674673428.USD","LU2468319806.SGD"],"gpt_icon":0},{"id":"2573600244","title":"Gilead Sciences (GILD) Gets a Buy from TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2573600244","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573600244?lang=en_us&edition=fundamental","pubTime":"2025-10-07 03:35","pubTimestamp":1759779326,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Tyler Van Buren maintained a Buy rating on Gilead Sciences on October 3 and set a price target of $115.00. The company’s shares op...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-gets-a-buy-from-td-cowen-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-gets-a-buy-from-td-cowen-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BKVL7J92.USD","LU0882574055.USD","BK4585","BK4566","IE00B3T34201.USD","BK4583","BK4550","LU1571399168.USD","LU1066053197.SGD","LU0058720904.USD","GILD","LU0109394709.USD","SG9999015952.SGD","IE00B7SZLL34.SGD","LU2324357040.USD","IE00BZ1G4Q59.USD","LU2087621335.USD","LU1778281490.HKD","LU2089984988.USD","LU1066051498.USD","LU1430594728.SGD","SG9999015986.USD","LU0320765992.SGD","LU1674673691.USD","LU0289739699.SGD","LU1839511570.USD","BK4588","BK4139","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU0889565916.HKD","BK4578","SG9999015945.SGD","TD","LU2468319806.SGD","LU1674673428.USD","SG9999015978.USD","LU0114720955.EUR","LU0234570918.USD","LU1585245621.USD","BK4207","BK4127","IE00BSNM7G36.USD","BK4532","LU0823416689.USD","BK4568","IE0002270589.USD","COWN"],"gpt_icon":0},{"id":"2573601176","title":"Gilead Reaches Settlement To Block Biktarvy Generics Until 2036","url":"https://stock-news.laohu8.com/highlight/detail?id=2573601176","media":"Benzinga_recent_news","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573601176?lang=en_us&edition=fundamental","pubTime":"2025-10-07 00:24","pubTimestamp":1759767840,"startTime":"0","endTime":"0","summary":"Gilead Sciences settled patent disputes with Lupin, Cipla, and Laurus, delaying U.S. generic entry of HIV drug Biktarvy until April 2036.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/06/Feb-19--2020-Foster-City-----Ca-----Usa-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/06/Feb-19--2020-Foster-City-----Ca-----Usa-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/legal/25/10/48049621/gilead-reaches-settlement-to-block-biktarvy-generics-until-2036","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/legal/25/10/48049621/gilead-reaches-settlement-to-block-biktarvy-generics-until-2036","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU0320765992.SGD","SG9999015945.SGD","GILD","LU1571399168.USD","IE0002270589.USD","LU2087621335.USD","IE00BZ1G4Q59.USD","LU2089984988.USD","BK4585","SG9999015952.SGD","LU0109394709.USD","LU0889565916.HKD","BK4550","BK4566","IE00B19Z3B42.SGD","LU1674673428.USD","LU0058720904.USD","LU1066051498.USD","LU2468319806.SGD","BK4583","LU0114720955.EUR","SG9999015978.USD","BK4578","BK4568","IE00B19Z3581.USD","SG9999015986.USD","BK4139","LU0289739699.SGD","LU0882574055.USD","IE00B3T34201.USD","IE00BSNM7G36.USD","BK4532","IE00B7SZLL34.SGD","LU2324357040.USD","LU1430594728.SGD","LU1778281490.HKD","LU1066053197.SGD","LU1839511570.USD","LU0823416689.USD","LU0234570918.USD","LU1585245621.USD","BK4588","IE00BKVL7J92.USD","LU1674673691.USD"],"gpt_icon":0},{"id":"2573670900","title":"BUZZ-Gilead up after settling patent litigations with some generic drugmakers","url":"https://stock-news.laohu8.com/highlight/detail?id=2573670900","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573670900?lang=en_us&edition=fundamental","pubTime":"2025-10-06 21:20","pubTimestamp":1759756845,"startTime":"0","endTime":"0","summary":"BUZZ-Gilead up after settling patent litigations with some generic drugmakers** Shares of drugmaker Gilead Sciences GILD.O climb 4.1% to $117.28 premarket** Company says it resolved patent litigations with Indian drugmakers Lupin, Cipla and Laurus Labs, which had filed a marketing application for generic versions of GILD's HIV drug Biktarvy** GILD says no generic entry of certain versions of the drug is expected prior to April 1, 2036 in the United States** Up to last close, GILD shares up 22% YTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nL3N3VN0R0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","SG9999015952.SGD","LU1430594728.SGD","IE00BZ1G4Q59.USD","LU2324357040.USD","LU0289739699.SGD","BK4566","BK4550","IE00B7SZLL34.SGD","SG9999015986.USD","BK4139","GILD","IE00BSNM7G36.USD","BK4585","BK4532","LU0109394709.USD","LU0114720955.EUR","SG9999015945.SGD","IE00BKVL7J92.USD","LU0234570918.USD","LU1066051498.USD","LU1066053197.SGD","LU1674673428.USD","LU1778281490.HKD","BK4568","LU2468319806.SGD","LU1571399168.USD","LU1839511570.USD","LU2087621335.USD","IE00B19Z3581.USD","LU0889565916.HKD","LU1585245621.USD","LU0882574055.USD","IE00B3T34201.USD","BK4578","LU2089984988.USD","BK4588","LU0823416689.USD","LU1674673691.USD","IE00B19Z3B42.SGD","IE0002270589.USD","SG9999015978.USD","BK4583","LU0320765992.SGD"],"gpt_icon":0},{"id":"2573729672","title":"BRIEF-Gilead Sciences Inc Announces Settlement Agreements With Lupin, Cipla And Laurus Labs - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2573729672","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573729672?lang=en_us&edition=fundamental","pubTime":"2025-10-06 20:37","pubTimestamp":1759754269,"startTime":"0","endTime":"0","summary":"BRIEF-Gilead Sciences Inc Announces Settlement Agreements With Lupin, Cipla And Laurus Labs - SEC FilingOct 6  - Gilead Sciences Inc GILD.O:GILEAD SCIENCES INC - ANNOUNCES SETTLEMENT AGREEMENTS WITH LUPIN, CIPLA AND LAURUS LABS TO RESOLVE PATENT LITIGATIONS - SEC FILINGGILEAD SCIENCES INC - NO GENERIC ENTRY FOR BIKTARVY EXPECTED BEFORE APRIL 1, 2036 - SEC FILINGFurther company coverage: GILD.O ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nFWN3VN1SX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","IE0002270589.USD","LU0109394709.USD","LU1430594728.SGD","BK4578","LU1066051498.USD","LU2324357040.USD","LU1674673428.USD","LU2468319806.SGD","SG9999015945.SGD","IE00B3T34201.USD","LU0234570918.USD","BK4583","IE00BZ1G4Q59.USD","LU2087621335.USD","IE00BKVL7J92.USD","SG9999015952.SGD","GILD","BK4568","LU0823416689.USD","BK4566","BK4532","BK4550","LU0889565916.HKD","LU1585245621.USD","LU1674673691.USD","SG9999015986.USD","BK4585","IE00B7SZLL34.SGD","LU0320765992.SGD","LU1839511570.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU1571399168.USD","LU2089984988.USD","BK4588","LU0289739699.SGD","SG9999015978.USD","LU1066053197.SGD","LU0114720955.EUR","IE00B19Z3581.USD","LU0058720904.USD","BK4139","LU1778281490.HKD"],"gpt_icon":0},{"id":"2573723626","title":"Gilead Sciences Inc - Announces Settlement Agreements With Lupin, Cipla and Laurus Labs to Resolve Patent Litigations - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2573723626","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573723626?lang=en_us&edition=fundamental","pubTime":"2025-10-06 20:19","pubTimestamp":1759753147,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nFWN3VN1SX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GILD","BK4588","LU0882574055.USD","LU1066053197.SGD","BK4585","SG9999015978.USD","BK4550","LU0823416689.USD","SG9999015945.SGD","BK4532","LU0289739699.SGD","LU0114720955.EUR","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU0889565916.HKD","BK4566","LU1066051498.USD","LU2089984988.USD","LU2087621335.USD","LU0058720904.USD","LU2324357040.USD","BK4568","LU1839511570.USD","IE00B19Z3581.USD","LU0320765992.SGD","BK4139","BK4583","IE00BSNM7G36.USD","IE00BZ1G4Q59.USD","LU1674673428.USD","SG9999015952.SGD","BK4578","IE0002270589.USD","LU1674673691.USD","LU1430594728.SGD","LU1585245621.USD","LU2468319806.SGD","LU1571399168.USD","SG9999015986.USD","IE00B3T34201.USD","IE00B7SZLL34.SGD","LU0234570918.USD","LU1778281490.HKD","LU0109394709.USD"],"gpt_icon":0},{"id":"2573672364","title":"Gilead Sciences Inc - No Generic Entry for Biktarvy Expected Before April 1, 2036 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2573672364","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573672364?lang=en_us&edition=fundamental","pubTime":"2025-10-06 20:19","pubTimestamp":1759753147,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nFWN3VN1SX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU1066053197.SGD","BK4139","LU0109394709.USD","SG9999015978.USD","BK4568","SG9999015945.SGD","LU0289739699.SGD","BK4550","LU0234570918.USD","LU1674673691.USD","BK4585","BK4532","IE00B7SZLL34.SGD","LU2324357040.USD","LU0058720904.USD","LU0889565916.HKD","LU2087621335.USD","SG9999015986.USD","LU0114720955.EUR","BK4566","LU0882574055.USD","BK4578","LU1430594728.SGD","LU1066051498.USD","BK4583","BK4588","LU0823416689.USD","LU2468319806.SGD","LU1778281490.HKD","LU1585245621.USD","IE00BZ1G4Q59.USD","LU1839511570.USD","IE00BKVL7J92.USD","LU2089984988.USD","LU1674673428.USD","SG9999015952.SGD","GILD","IE00B3T34201.USD","IE00BSNM7G36.USD","LU0320765992.SGD","LU1571399168.USD","IE0002270589.USD"],"gpt_icon":0},{"id":"2573672354","title":"Gilead Sciences Reaches Settlement to Delay U.S. Generic Versions of Biktarvy Until 2036","url":"https://stock-news.laohu8.com/highlight/detail?id=2573672354","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573672354?lang=en_us&edition=fundamental","pubTime":"2025-10-06 20:17","pubTimestamp":1759753071,"startTime":"0","endTime":"0","summary":"Gilead Sciences Inc. has reached settlement agreements with Lupin Ltd., Cipla Ltd., and Laurus Labs Ltd. to resolve ongoing patent litigation concerning generic versions of Biktarvy, the company's HIV treatment. As part of the agreements, which remain subject to standard acceleration provisions, generic versions of Biktarvy will not be introduced in the United States before April 1, 2036. The settlements follow legal challenges from the generic manufacturers, who had sought FDA approval to market their own versions of the drug.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nNDLJm7Bd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002270589.USD","LU0058720904.USD","BK4550","LU1585245621.USD","SG9999015952.SGD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","LU1571399168.USD","SG9999015945.SGD","LU0109394709.USD","LU1674673691.USD","LU0320765992.SGD","BK4583","LU1778281490.HKD","LU1066051498.USD","IE00B3T34201.USD","BK4585","BK4588","BK4139","BK4532","IE00BZ1G4Q59.USD","LU1430594728.SGD","LU2089984988.USD","SG9999015978.USD","LU1066053197.SGD","GILD","LU0889565916.HKD","LU1839511570.USD","LU0823416689.USD","LU2468319806.SGD","BK4578","LU0882574055.USD","BK4568","LU2324357040.USD","LU0114720955.EUR","IE00BKVL7J92.USD","BK4566","LU0234570918.USD","SG9999015986.USD","IE00BSNM7G36.USD","LU2087621335.USD","LU0289739699.SGD","LU1674673428.USD"],"gpt_icon":0},{"id":"2572630363","title":"Gilead's Lost Decade Is Over. Time To Buy In. -- Barron's","url":"https://stock-news.laohu8.com/highlight/detail?id=2572630363","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572630363?lang=en_us&edition=fundamental","pubTime":"2025-10-04 09:30","pubTimestamp":1759541400,"startTime":"0","endTime":"0","summary":"Gilead looks attractive again. Its innovative edge and new crop of medications are performing well across multiple specialties. By Teresa Rivas. No good deed goes unpunished. Gilead Sciences' stock is proof. It's time for investors to give the biotech another look.A little more than a decade ago, Gilead introduced Sovaldi and Harvoni, medications for the liver disease hepatitis C that were truly revolutionary. The stock shot up to a record intraday high of more than $122 in 2015. As it turned out, the drugs worked so well that many patients didn't need ongoing treatment, and headlines mostly fixated on the roughly $95,000 price tag. Gilead shares started a long decline, and only now, some 10 years later, have they approached their previous high.Oncology is also doing well. Gilead's Trodelvy antibody-drug conjugate, or ADC, returned to growth in the quarter to the tune of 14% year over year. Its CAR T-cell therapy franchise, a category of treatment that uses personalized inputs to harne","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1585245621.USD","BK4583","BK4568","LU0823416689.USD","SG9999015978.USD","BK4139","GILD","LU1066053197.SGD","LU0114720955.EUR","BK4566","BK4585","BK4532","BK4550","IE00B19Z3581.USD","LU1674673428.USD","LU1778281490.HKD","LU2468319806.SGD","IE0002270589.USD","IE00BKVL7J92.USD","LU0289739699.SGD","LU1066051498.USD","LU1571399168.USD","LU0234570918.USD","IE00B3T34201.USD","LU1674673691.USD","IE00B19Z3B42.SGD","SG9999015952.SGD","BK4578","IE00BSNM7G36.USD","LU1430594728.SGD","LU0320765992.SGD","LU0889565916.HKD","LU2324357040.USD","IE00BZ1G4Q59.USD","LU2087621335.USD","LU2089984988.USD","SG9999015945.SGD","LU1839511570.USD","IE00B7SZLL34.SGD","LU0058720904.USD","SG9999015986.USD","BK4588","ACLX","LU0882574055.USD","LU0109394709.USD"],"gpt_icon":0},{"id":"2572337636","title":"Gilead Sciences Inc. Reports Acquisition of Common Shares of Assembly Biosciences Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2572337636","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572337636?lang=en_us&edition=fundamental","pubTime":"2025-10-04 04:31","pubTimestamp":1759523483,"startTime":"0","endTime":"0","summary":"Gilead Sciences, Inc. has reported the acquisition of common shares of Assembly Biosciences Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Assembly Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 03, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251003:nNDL5jfWrs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051498.USD","IE00B3T34201.USD","LU0109394709.USD","ASMB","LU1674673691.USD","LU0058720904.USD","LU0882574055.USD","SG9999015952.SGD","BK4566","IE00BSNM7G36.USD","IE0002270589.USD","BK4568","LU1674673428.USD","LU2324357040.USD","GILD","IE00B19Z3B42.SGD","BK4550","IE00BZ1G4Q59.USD","LU1839511570.USD","SG9999015945.SGD","BK4532","LU1778281490.HKD","LU2089984988.USD","LU0320765992.SGD","IE00B7SZLL34.SGD","BK4585","IE00BKVL7J92.USD","LU0234570918.USD","LU2087621335.USD","SG9999015978.USD","SG9999015986.USD","BK4583","BK4578","LU1585245621.USD","LU0889565916.HKD","LU1066053197.SGD","LU2468319806.SGD","IE00B19Z3581.USD","LU0823416689.USD","BK4139","BK4588","LU1430594728.SGD","LU1571399168.USD","LU0114720955.EUR","LU0289739699.SGD"],"gpt_icon":0},{"id":"2572872816","title":"BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2025-10-03","url":"https://stock-news.laohu8.com/highlight/detail?id=2572872816","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572872816?lang=en_us&edition=fundamental","pubTime":"2025-10-04 02:45","pubTimestamp":1759517107,"startTime":"0","endTime":"0","summary":"BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2025-10-03Nasdaq 100 .NDXTop PerformersPercent ChangeShopify Inc SHOP.OQ+5.9%Charter Communications Inc CHTR.OQ+3.7%Intuitive Surgical Inc ISRG.OQ+2.6%Gilead Sciences Inc GILD.OQ+2.5%Diamondback Energy Inc FANG.OQ+2.4%Bottom PerformersPercent ChangePalantir Technologies Inc PLTR.OQ-6.6%Tesla Inc TSLA.OQ-3.0%Advanced Micro Devices Inc AMD.OQ-3.0%MercadoLibre Inc MELI.OQ-3.0%KLA Corp KLAC.OQ-2.9%The Nasdaq 100 .NDX lost 86.83 points, or 0.35%, to 24,805.96 and recorded 7 new highs and no new lows. 59 stocks rose and 42 fell as advancing issues outnumbered decliners by a about a 1.4-to-1 ratio.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251003:nL5N3VK15K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4516","SHOP","LU2360106780.USD","LU0058720904.USD","LU1868838027.USD","LU2063271972.USD","KLAC","IE0004445239.USD","LU0050427557.USD","BK4511","CHTR","LU1712237335.SGD","BK4555","IE00B19Z8X17.USD","ISRG","GILD","LU2087621335.USD","LU1974910355.USD","PLTR","BK4578","MELI","BK4141","IE00B19Z9P08.USD","LU1201861249.SGD","LU1366192091.USD","IE00B894F039.SGD","LU0820561909.HKD","LU1623119135.USD","LU1852331112.SGD","BK4575","FANG","LU0081259029.USD","LU0320765992.SGD","IE00B7SZLL34.SGD","GB00BDT5M118.USD","BK4554","LU2357305700.SGD","AMD","SGXZ99366536.SGD","LU0198837287.USD","LU2264538146.SGD","SG9999015978.USD","BK4099","BK4220","TSLA","TSYW.SI","LU0689472784.USD","BK4598","LU1880398554.USD","LU1201861165.SGD"],"gpt_icon":1}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":33,"code":"91000000","status":"200"}]}}